{"id":6265,"date":"2020-11-26T09:17:59","date_gmt":"2020-11-26T09:17:59","guid":{"rendered":"https:\/\/www.library.sath.nhs.uk\/research\/?p=6265"},"modified":"2020-11-26T09:18:51","modified_gmt":"2020-11-26T09:18:51","slug":"hypertension-in-copd-a-review-of-current-practice-2020","status":"publish","type":"post","link":"https:\/\/www.library.sath.nhs.uk\/research\/2020\/11\/26\/hypertension-in-copd-a-review-of-current-practice-2020\/","title":{"rendered":"Hypertension in COPD: A review of current practice (2020)"},"content":{"rendered":"<p><strong>Type of publication:<\/strong><br \/>\nPoster presentation<\/p>\n<p><strong>Author(s):<\/strong><br \/>\n*Richard Cooper, *Wong Po Fung, *Alison Perry, *James Greenway, *Harmesh Moudgil, *Koottalai Srinivasan, *Annabel Makan, *Emma Crawford, *Nawaid Ahmad<\/p>\n<p><strong>Citation:<\/strong><br \/>\nEuropean Respiratory Journal 2020; 56: Suppl. 64, 184.<\/p>\n<p><strong>Abstract:<\/strong><br \/>\nBackground: Patients with COPD are susceptible to cardiovascular events and a recent review article has outlined management of Hypertension in the COPD population [Finks S et al. N Engl J Med 2020;382:353-63]. It is not known how the authors\u2019 suggestions translate into practice, so review was undertaken of a UK District General Hospital population.<br \/>\nAims: The aim was to review management of hypertensive COPD patients; choice of anti-hypertensive medication, and correlations with morbidity and mortality<br \/>\nMethods: This was a retrospective analysis of all COPD patients who presented to hospital with an exacerbation between October and December 2019. Patients without a history of hypertension were excluded.<br \/>\nResults: 151 patients were admitted during this period. 71\/151 were known hypertension. 52% were female, Mean Age (SD) 74 (10) years. 83% (n=59\/71) were on anti-hypertensive medication\/s (AH) of which 44% (n=26\/59), 42% (n=25\/59), 12% (7\/59) and 2% (1\/59) were on one, two, three and four AH respectively. 42% (30\/71) patients had an exacerbation in the last 12 months and 97% (29\/30) were on \u22651 AH. Unadjusted 30 day mortality was 11% (n=8\/71) of which 88% (7\/8) were on \u22651 AH. n=2\/3 patients on beta blockers, n=2\/5 on angiotensin receptor blockers (ARB), n=6\/12 on calcium channel blockers (CCB), n=3\/4 on ACE-inhibitors and 1\/1 on Alpha blocker as a single AH had an exacerbation in the last 12 months. More patients on loop diuretics (LD) had chronic type 2 respiratory failure (n=5) or exacerbations in the last 12 months (n=10).<br \/>\nConclusions:<br \/>\n1.CCB is the most commonly used AH agent<br \/>\n2.Patients on ARBs were least likely to exacerbate<br \/>\n3.LD may contribute to more exacerbations and chronic type 2 respiratory failure<\/p>\n<p><a href=\"https:\/\/erj.ersjournals.com\/content\/56\/suppl_64\/184\">Link to more details<\/a>\u00a0[no password required]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Type of publication: Poster presentation Author(s): *Richard Cooper, *Wong Po Fung, *Alison Perry, *James Greenway, *Harmesh Moudgil, *Koottalai Srinivasan, *Annabel Makan, *Emma Crawford, *Nawaid Ahmad Citation: European Respiratory Journal 2020; 56: Suppl. 64, 184. Abstract: Background: Patients with COPD are<span class=\"ellipsis\">&hellip;<\/span><\/p>\n<div class=\"read-more\"><a href=\"https:\/\/www.library.sath.nhs.uk\/research\/2020\/11\/26\/hypertension-in-copd-a-review-of-current-practice-2020\/\">Read more <span class=\"screen-reader-text\">Hypertension in COPD: A review of current practice (2020)<\/span><span class=\"meta-nav\"> &#8250;<\/span><\/a><\/div>\n<p><!-- end of .read-more --><\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[200],"tags":[917,215,973],"class_list":["post-6265","post","type-post","status-publish","format-standard","hentry","category-staff-publication","tag-917","tag-copd","tag-hypertension"],"_links":{"self":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts\/6265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/comments?post=6265"}],"version-history":[{"count":2,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts\/6265\/revisions"}],"predecessor-version":[{"id":6267,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts\/6265\/revisions\/6267"}],"wp:attachment":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/media?parent=6265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/categories?post=6265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/tags?post=6265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}